# Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients

> **NCT05866653** · PHASE2 · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 90 (estimated)

## Conditions studied

- Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients

## Interventions

- **DRUG:** lidocaine transdermal patch

## Key facts

- **NCT ID:** NCT05866653
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-25
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-07-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2023-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05866653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05866653, "Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05866653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*